Safety concerns regarding combination vaccines: The experience in Japan

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 3911-3916

  Andreae, Margie C ^a   Freed, Gary L ^a   Katz, Samuel L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

MMR; Safety; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES VACCINE; MONOVALENT CATION; MUMPS VACCINE; RUBELLA VACCINE;

ACTIVE IMMUNIZATION; ANTIGENICITY; ARTICLE; ASEPTIC MENINGITIS; CONTROLLED STUDY; DIPHTHERIA; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG WITHDRAWAL; EXPERIENCE; GOVERNMENT; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INTERVIEW; JAPAN; MEASLES; MUMPS; ORGANIZATION; PERTUSSIS; PRIORITY JOURNAL; RUBELLA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TETANUS; VACCINATION;

CHILD; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENDEMIC DISEASES; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; JAPAN; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; RUBELLA; VACCINATION; VACCINES, COMBINED;

EID: 4444260257     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.013     Document Type: Article

References (41)

1. Chen R.T., DeStefano F., Pless R., Mootrey G., Kramarz P., Hibbs B. Challenges and controversies in immunization safety. Infect. Dis. Clin. North Am. 15(1):2001;21-39., viii
2. Poland G.A., Jacobson R.M. Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine. 19(17-19):2001;2440-2445
3. Gellin B.G., Maibach E.W., Marcuse E.K. Do parents understand immunizations? A national telephone survey. Pediatrics. 106(5):2000;1097-1102
4. Hinman A.R. How should physicians and nurses deal with people who do not want immunizations? Can. J. Public Health. 91(4):2000;248-251
5. Freed G.L., Katz S.L., Clark S.J. Safety of vaccinations. Miss America, the media, and public health. J. Am. Med. Assoc. 276(23):1996;1869-1872
6. Freed G.L., Andreae M.C., Cowan A.E., Katz S.L. Vaccine safety policy analysis in three European countries: the case of thimerosal. Health Policy. 62(3):2002;291-307
7. Combination vaccines for childhood immunization. MMWR Recomm Rep 1999;48(RR-5):1-14.
8. Fischman J. The safety of taking lots of shots. In: US News and World Report; 2002. p. 60.
9. Wakefield A.J., Murch S.H., Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 351(9103):1998;637-641
10. Wakefield AJ. Testimony before congressional oversight committee on autism and immunization. In: Presented at the 106th Congress of the Committee on Government Reform; 2000.
11. Pope J. Parents push for change in vaccine policy: 3-in-1 shot blamed for doing damage. In: The Times-Picayune, New Orleans; 1999. p. 1B.
12. Kmietowicz Z. Separate vaccines could endanger children. Br. Med. J. 323(7315):2001;711
13. Japanese Information Network Information Bulletin No. 10. Access Web site; 1995. Available from: http://www.jin.jcic.or.jp (US Mirror Site: http://www.jinjapan.org/).
14. Ikegami N, Campbell JC, editors. Containing health care costs in Japan. Ann Arbor: University of Michigan Press; 1996. p. 311.
15. Matsudaira T. The economic benefit of vaccination. Jpn. Med. Assoc. J. 44(10):2001;448-451
16. Hirayama M. Strategy and program of immunization in Japan. Tokyo, Japan: Nippon Aiiku Institute for Maternal and Child Health and Welfare; 2001.
17. WHO. Country Report Japan. Manila, Philippines; 13-15 August 2001.
18. Kimura M., Kuno-Sakai H. Developments in pertussis immunisation in Japan. Lancet. 336(8706):1990;30-32
19. Noble G.R., Bernier R.H., Esber E.C. et al Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. J. Am. Med. Assoc. 257(10):1987;1351-1356
20. Kanai K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn. J. Med. Sci. Biol. 33(3):1980;107-143
21. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use - supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1992;41(RR-1):1-10.
22. Gangarosa E.J., Galazka A.M., Wolfe C.R., et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 351(9099):1998;356-361
23. WHO. Review of National Immunization Coverage 1980-1999, Japan; September 2001.
24. Mori I., Torii S., Hamamoto Y., Kanda A., Tabata Y., Nagafuji H. Virological evaluation of mumps meningitis following vaccination against mumps. Kansenshogaku Zasshi. 65(2):1991;226-233
25. Kimura M., Kuno-Sakai H., Yamazaki S., et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr. Jpn. 38(3):1996;205-211
26. Health and immunization for children. Tokyo, Japan: Bureau of Public Health, Tokyo Metropolitan Government; 2001.
27. WHO Vaccines, Immunization and Biologicals: 2002 Summary Country Profile (Japan). Access 2002. Available from: http://www-nt.who.int/vaccines/ GlobalSummary/Immunization/CountryProfileSelect.cfm.
28. From the Centers for Disease Control. Measles-United States, 2000. J Am Med Assoc 2002;287(9):1105-6.
29. Measles, Japan, 1999-2001. Infectious Agents Surveillance Report. Access November 2001. Available from: http://idsc.nih.go.jp/iasr/22/261/tpc261.html.
30. From the Centers for Disease Control and Prevention. Transmission of measles among a highly vaccinated school population - Anchorage, Alaska, 1998. J Am Med Assoc 1999;281(4):315-6.
31. The present status of measles in Japan as of 1998. In: Infectious Agents Surveillance Report, vol. 20; 1999. p. 27-8.
32. Anderson R.M., May R.M. Immunisation and herd immunity. Lancet. 335(8690):1990;641-645
33. Kane M. Complacency cure. Seattle Post-Intelligencer. Access Opinion. 28 February 2001. Available from: URL: http://www.seattlepi.com/opinion/path28. shtml.
34. Ueda K. Measles vaccine/rubella vaccine. Jpn. Med. Assoc. J. 44(10):2001;427-433
35. Rubella, Japan, 1999-2002. In: Infectious Agents Surveillance Report, vol. 24; 2003. p. 53-4.
36. Mumps, Japan, 1993-2002. In: Infectious Agents Surveillance Report, vol. 24; 2003. p. 103-4.
37. Parrish B. Vaccine and subsequent cases of autism suspected. Parish & Company. Access 2000. Available from: http://www.apfn.org/apfn/vaccine2.htm.
38. Hope J. Why Japan banned MMR vaccine. Daily Mail. Access. Available from: http://www.femail.co.uk/pages/standard/article.html?in_article_id= 17509&in_page_id=25.
39. Andreae MA, Freed GL, Katz SL. Safety concerns regarding combination vaccines: perspective of select European countries. In: Health Policy; 2003.
40. Dales L., Hammer S.J., Smith N.J. Time trends in autism and in MMR immunization coverage in California. J. Am. Med. Assoc. 285(9):2001;1183-1185
41. Madsen K.M., Hviid A., Vestergaard M., et al. A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347(19):2002;1477-1482